全文获取类型
收费全文 | 190750篇 |
免费 | 1733篇 |
国内免费 | 137篇 |
专业分类
耳鼻咽喉 | 1242篇 |
儿科学 | 6938篇 |
妇产科学 | 3565篇 |
基础医学 | 18262篇 |
口腔科学 | 1980篇 |
临床医学 | 13583篇 |
内科学 | 34672篇 |
皮肤病学 | 951篇 |
神经病学 | 18107篇 |
特种医学 | 9523篇 |
外科学 | 31068篇 |
综合类 | 2355篇 |
一般理论 | 1篇 |
预防医学 | 18503篇 |
眼科学 | 3048篇 |
药学 | 10395篇 |
中国医学 | 646篇 |
肿瘤学 | 17781篇 |
出版年
2023年 | 172篇 |
2022年 | 147篇 |
2021年 | 455篇 |
2020年 | 393篇 |
2019年 | 480篇 |
2018年 | 22399篇 |
2017年 | 17678篇 |
2016年 | 19869篇 |
2015年 | 1431篇 |
2014年 | 1532篇 |
2013年 | 1609篇 |
2012年 | 8229篇 |
2011年 | 22242篇 |
2010年 | 19469篇 |
2009年 | 12143篇 |
2008年 | 20466篇 |
2007年 | 22651篇 |
2006年 | 1525篇 |
2005年 | 3045篇 |
2004年 | 4216篇 |
2003年 | 5064篇 |
2002年 | 3094篇 |
2001年 | 416篇 |
2000年 | 571篇 |
1999年 | 323篇 |
1998年 | 317篇 |
1997年 | 293篇 |
1996年 | 182篇 |
1995年 | 199篇 |
1994年 | 168篇 |
1993年 | 122篇 |
1992年 | 139篇 |
1991年 | 180篇 |
1990年 | 182篇 |
1989年 | 135篇 |
1988年 | 100篇 |
1987年 | 86篇 |
1986年 | 66篇 |
1985年 | 66篇 |
1984年 | 56篇 |
1983年 | 53篇 |
1982年 | 52篇 |
1980年 | 49篇 |
1974年 | 27篇 |
1970年 | 30篇 |
1969年 | 28篇 |
1938年 | 60篇 |
1934年 | 30篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Ruscitti Piero Di Cola Ilenia Berardicurti Onorina Conforti Alessandro Iacono Daniela Pantano Ilenia Rozza Gelsomina Rossi Silvia De Stefano Ludovico Balduzzi Silvia Vitale Antonio Caso Francesco Costa Luisa Prete Marcella Navarini Luca Atzeni Fabiola Guggino Giuliana Perosa Federico Cantarini Luca Frediani Bruno Montecucco Carlomaurizio Ciccia Francesco Giacomelli Roberto Cipriani Paola 《Clinical rheumatology》2022,41(11):3597-3597
Clinical Rheumatology - 相似文献
2.
Marco N. Iannone Stefano Stucchi Elia A. Turolla Chiara Beretta Samuele Ciceri Clizia Chinello Lisa Pagani Sergio Todde Patrizia Ferraboschi 《Journal of labelled compounds & radiopharmaceuticals》2022,65(3):48-62
In the last decade, the development of new radiopharmaceuticals for the imaging and therapy of prostate cancer has been a highly active and important area of research, especially focusing on the prostate-specific membrane antigen (PSMA), an antigen which is upregulated in prostate, as well as in other tumor cells. A large variety of PSMA ligands have been radiolabeled, to date. Among the various derivatives, PSMA-617 resulted to be one of the most interesting in terms of interaction with the antigen and clinical properties, and its lutetium-177 labeled version has recently been approved by regulatory agencies for therapeutic purposes. For this reasons, the radiolabeling with fluorine-18 of a PSMA-617 derivative might be of interest. Beside other methodologies to radiolabel macromolecules with fluorine-18, the “click-chemistry” approach resulted to be very useful, and the copper-catalyzed azide-alkyne cycloaddition (CuAAC) is considered one of most efficient and reliable. This paper proposes the synthesis of a suitable precursor for the radiolabeling with fluorine-18 of a new PSMA-617 derivative. The whole radiosynthetic procedure has been fully automated, and the final product, which proved to be stable in plasma, has been obtained with radiochemical yield and purity suitable for subsequent preclinical studies. 相似文献
3.
Simone Oerlemans PhD Fabio Efficace PhD Charalampia Kyriakou PhD MD Ana Carolina Freitas PhD MD Omar Shamieh PhD MD Carien L. Creutzberg PhD MD Jens Lehmann PhD Duska Petranovic PhD MD Eva Nagele PhD Anne Bredart PhD Dong Dong PhD Christian W. Scholz PhD MD Giovanni Caocci PhD MD Stefano Molica PhD MD Laimonas Griskevicius PhD MD Aliki Xochelli PhD MD Jacobien M. Kieffer PhD Joost A. Agelink van Rentergem PhD Waleed Alrjoub BSN Anja Mueller PhD Maria Gomes Da Silva PhD MD Filipa Alves da Costa PhD PharmD Sandra Malak PhD MD Kim Cocks PhD Lonneke V. van de Poll-Franse PhD the EORTC Quality of Life Group 《Cancer》2023,129(17):2727-2740
Background
Health-related quality of life (HRQOL) is a critical aspect to consider when making treatment decisions for patients with non-Hodgkin-lymphoma (NHL). This international study by the European Organisation for Research and Treatment of Cancer (EORTC) tested the psychometric properties of two newly developed measures for patients with high-grade (HG)- and low-grade (LG)-NHL: the EORTC QLQ-NHL-HG29 and the EORTC QLQ-NHL-LG20 to supplement the core questionnaire (EORTC QLQ-C30).Methods
Overall, 768 patients with HG-NHL (N = 423) and LG-NHL (N = 345) from 12 countries completed the QLQ-C30, QLQ-NHL-HG29/QLQ-NHL-LG20 and a debriefing questionnaire at baseline, and a subset at follow-up for either retest (N = 125/124) or responsiveness to change (RCA; N = 98/49).Results
Confirmatory factor analysis showed an acceptable to good fit of the 29 items of the QLQ-NHL-HG29 on its five scales (symptom burden [SB], neuropathy, physical condition/fatigue [PF], emotional impact [EI], and worries about health/functioning [WH]), and of the 20 items of the QLQ-NHL-LG20 on its four scales (SB, PF, EI, and WH). Completion took on average 10 minutes. Test–retest reliability, convergent validity, known-group comparisons, and RCA find satisfactory results of both measures. A total of 31%–78% of patients with HG-NHL and 22%–73% of patients with LG-NHL reported symptoms and/or worries (e.g., tingling in hands/feet, lack of energy, and worries about recurrence). Patients reporting symptoms/worries had substantially lower HRQOL compared to those without.Discussion
The use of the EORTC QLQ-NHL-HG29 and QLQ-NHL-LG20 questionnaires in clinical research and practice will provide clinically relevant data to better inform treatment decision-making.Plain language summary
- The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group developed two questionnaires.
- These questionnaires measure health-related quality of life.
- The questionnaires are for patients with high-grade or low-grade non-Hodgkin lymphoma.
- They are called the EORTC QLQ-NHL-HG29 and QLQ-NHL-LG20.
- The questionnaires are now internationally validated.
- This study demonstrates that the questionnaires are reliably and valid, which are important aspects of a questionnaire.
- The questionnaires can now be used in clinical trials and practice.
- With the information gathered from the questionnaires, patients and clinicians can better evaluate treatments and discuss the best choice for a patient.
4.
Benenati Stefano Toma Matteo Canale Claudia Vergallo Rocco Bona Roberta Della Ricci Davide Canepa Marco Crimi Gabriele Santini Francesco Ameri Pietro Porto Italo 《Heart failure reviews》2022,27(3):927-934
Heart Failure Reviews - To compare the efficacy and safety of different mechanical circulatory support (MCS) devices in CS. A total of 24 studies (7 randomized controlled... 相似文献
5.
6.
Giuseppe Vanella Domenico Tamburrino Gabriele Capurso Michiel Bronswijk Michele Reni Giuseppe Dell Anna Stefano Crippa Schalk Van der Merwe Massimo Falconi Paolo Giorgio Arcidiacono 《World journal of gastroenterology : WJG》2022,28(10):976-984
Upfront resection is becoming a rarer indication for pancreatic ductal adenocarcinoma, as biologic behavior and natural history of the disease has boosted indications for neoadjuvant treatments. Jaundice, gastric outlet obstruction and acute cholecystitis can frequently complicate this window of opportunity, resulting in potentially deleterious chemotherapy discontinuation, whose resumption relies on effective, prompt and long-lasting management of these complications. Although therapeutic endoscopic ultrasound (t-EUS) can potentially offer some advantages over comparators, its use in potentially resectable patients is primal and has unfairly been restricted for fear of potential technical difficulties during subsequent surgery. This is a narrative review of available evidence regarding EUS-guided choledochoduodenostomy, gastrojejunostomy and gallbladder drainage in the bridge-to-surgery scenario. Proof-of-concept evidence suggests no influence of t-EUS procedures on outcomes of eventual subsequent surgery. Moreover, the very high efficacy-invasiveness ratio over comparators in managing pancreatic cancer-related symptoms or complications can provide a powerful weapon against chemotherapy discontinuation, potentially resulting in higher subsequent resectability. Available evidence is discussed in this short paper, together with technical notes that might be useful for endoscopists and surgeons operating in this scenario. No published evidence supports restricting t-EUS in potential surgical candidates, especially in the setting of pancreatic cancer patients undergoing neoadjuvant chemotherapy. Bridge-to-surgery t-EUS deserves further prospective evaluation. 相似文献
7.
Alessandra Elvevi Elena Maria Elli Martina Luc Miki Scaravaglio Fabio Pagni Stefano Ceola Laura Ratti Pietro Invernizzi Sara Massironi 《World journal of gastroenterology : WJG》2022,28(29):3767-3779
Mastocytosis is a rare and heterogeneous disease characterized by various clinical and biological features that affect different prognoses and treatments. The disease is usually divided into 2 principal categories: cutaneous and systemic disease (SM). Clinical features can be related to mast cell (MC) mediator release or pathological MC infiltration. SM is a disease often hard to identify, and the diagnosis is based on clinical, biological, histological, and molecular criteria with different specialists involved in the patient’s clinical work-up. Among all manifestations of the disease, gastrointestinal (GI) symptoms are common, being present in 14%-85% of patients, and can significantly impair the quality of life. Here we review the data regarding GI involvement in SM, in terms of clinical presentations, histological and endoscopic features, the pathogenesis of GI symptoms, and their treatment. 相似文献
8.
Canosa Stefano Parmegiani Lodovico Charrier Lorena Gennarelli Gianluca Garello Cristina Granella Francesca Evangelista Francesca Monelli Giuseppe Guidetti Daniela Revelli Alberto Filicori Marco Bongioanni Francesca 《Journal of assisted reproduction and genetics》2022,39(1):67-73
Journal of Assisted Reproduction and Genetics - To study whether a new combination of different warming kits is clinically effective for vitrified human blastocysts. This is a longitudinal cohort... 相似文献
9.
Alberto Maria Colasante Mario Bartiromo Michele Nardolillo Stefano Guarino Pierluigi Marzuillo Giuseppe Salvatore R C Mangoni di S Stefano Emanuele Miraglia del Giudice Anna Di Sessa 《World Journal of Clinical Pediatrics》2022,11(6):455-462
Childhood obesity represents a complex disease with a well-known cardio metabolic burden including fatty liver, type 2 diabetes, metabolic syndrome, and cardiovascular disease. From a pathogenic point of view, insulin resistance (IR) represents the key factor underlying the spectrum of these obesity consequences. As observed in adults, recent data supported the occurrence of microalbuminuria (MA) as marker of early kidney dysfunction and its potential link with cardio metabolic factors also in children with obesity. In fact, a well-documented pathophysiological hypothesis both in adults and children supported an intimate correlation with the major feature of obesity such as IR through the influence of insulin on renal hemodynamics. Based on the clinical and prognostic relevance of this relationship in daily practice (including an increased risk of chronic kidney disease development overtime), more scientific attention needs to be paid to the evaluation of early kidney damage in children with obesity. In this paper, we attempt to address three debated questions regarding the intriguing liaison between IR and MA in children with obesity: (1) What is the prevalence of pediatric MA? (2) What is the state of art of MA in children with obesity? and (3) Is there a link between IR and MA in children with obesity? 相似文献
10.
Milani Paolo Mazzola Marco Cigada Mario Massacesi Amedeo Setaccioli Marco Moschini Stefania Ciaccia Stefano Scotti Fabrizio Mantovani Elena Soranna Davide Zambon Antonella Bergamini Fulvio 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(9):2847-2857
Graefe's Archive for Clinical and Experimental Ophthalmology - To propose an algorithm of the major and minor diagnostic criteria for macular myopic choroidal neovascularization (mCNV). This... 相似文献